Global Nuclear Imaging Devices And Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product Type;
SPECT systems, PET systems, and Planar Scintigraphy.By Application;
Oncology, Cardiology, Neurology, Other Applications (Orthopedics, Urology, Thyroid-related Disorders, and and Gastroenterology).By End User;
Hospitals, Imaging Centers, Academic & Research Institutes, and Other End Users (Pharmaceutical/Biotechnology Companies and CROs).By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Nuclear Imaging Devices And Equipment Market (USD Million), 2021 - 2031
In the year 2024, the Global Nuclear Imaging Devices And Equipment Market was valued at USD 3,102.30 million. The size of this market is expected to increase to USD 3,973.76 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 3.6%.
The global nuclear imaging devices and equipment market is experiencing robust growth, driven by advancements in medical imaging technology and the increasing prevalence of chronic diseases such as cancer and cardiovascular conditions. Nuclear imaging, a critical component of modern diagnostics, involves the use of small amounts of radioactive materials to diagnose and determine the severity of various diseases. These imaging techniques provide detailed pictures of what is happening inside the body at the molecular and cellular level, offering invaluable insights that guide treatment decisions and improve patient outcomes.
One of the primary factors contributing to the expansion of the nuclear imaging market is the continuous innovation in imaging technologies. Developments such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and hybrid imaging systems that combine PET or SPECT with computed tomography (CT) or magnetic resonance imaging (MRI) are enhancing diagnostic accuracy and efficiency. These advanced imaging modalities are increasingly being integrated into routine clinical practice, driven by their ability to provide high-resolution images and functional information that are critical for early diagnosis and management of diseases.
The aging global population and the rising incidence of chronic diseases are significant drivers of market growth. As populations age, the demand for diagnostic imaging procedures to manage health conditions associated with aging, such as Alzheimer’s disease and other neurodegenerative disorders, is escalating. Additionally, the growing awareness and adoption of early diagnostic practices among healthcare providers and patients alike are fostering market expansion, as early detection is key to improving treatment outcomes and reducing healthcare costs.
Global Nuclear Imaging Devices And Equipment Market Recent Developments
- In 2023, the global nucnd equipment market grew with the increased adoption of PET and SPECT technologies for diagnosing cancers and neurological disorders .
- In 2024, the launch of more compact, portable nuclear imaging devices by companies like Siemens Healthineerlped boost access to nuclear imaging in smaller hospitals and outpatient clinics .
Segment Analysis
This report extensively covers different segments of Global Nuclear Imaging Devices And Equipment Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
The global nuclear imaging devices and equipment market is anticipated to witness substantial growth from 2024 to 2030, driven by advancements in medical technology, increasing prevalence of chronic diseases, and rising demand for non-invasive diagnostic techniques. Key product segments in this market include SPECT systems, PET systems, and planar scintigraphy, each playing a crucial role in the early detection and management of various medical conditions. The development and integration of AI and machine learning in imaging systems are expected to enhance diagnostic accuracy and efficiency, further propelling market growth.
The application spectrum of nuclear imaging devices is broad, encompassing oncology, cardiology, neurology, and other areas such as orthopedics, urology, thyroid-related disorders, and gastroenterology. Oncology remains the dominant segment due to the increasing incidence of cancer worldwide and the critical role of nuclear imaging in early cancer detection, staging, and monitoring. Cardiology and neurology are also significant segments, driven by the rising prevalence of cardiovascular and neurological disorders. The ability of nuclear imaging to provide detailed insights into organ function and disease progression makes it indispensable across these applications.
End users of nuclear imaging devices include hospitals, imaging centers, academic and research institutes, and other entities like pharmaceutical/biotechnology companies and contract research organizations (CROs). Hospitals constitute the largest end-user segment due to their extensive infrastructure and higher patient volume. Imaging centers are also growing rapidly, supported by the increasing trend of outpatient diagnostic procedures. Academic and research institutes continue to invest in advanced imaging technologies for innovative research and development, while pharmaceutical and biotech companies leverage these devices for drug development and clinical trials.
Global Nuclear Imaging Devices And Equipment Segment Analysis
In this report, the Global Nuclear Imaging Devices And Equipment Market has been segmented by Product Type, Application, End User, and Geography.
Global Nuclear Imaging Devices And Equipment Market, Segmentation by Product Type
The Global Nuclear Imaging Devices And Equipment Market has been segmented by Product Type into SPECT systems, PET systems, and Planar Scintigraphy.
The Global Nuclear Imaging Devices and Equipment Market is broadly categorized by product type into SPECT systems, PET systems, and Planar Scintigraphy. SPECT systems, or Single Photon Emission Computed Tomography, are widely used in clinical settings for their ability to provide detailed 3D images of the body's internal functions. This system is particularly effective in detecting and monitoring conditions such as heart disease, infections, and certain types of cancers. The increasing prevalence of these conditions drives the demand for advanced SPECT systems.
PET systems, or Positron Emission Tomography, offer another critical imaging technique, renowned for its high sensitivity in detecting abnormal metabolic activity. PET systems are often used in oncology, neurology, and cardiology to provide insights into complex diseases at an early stage. Their ability to visualize biochemical changes in the body before structural changes become apparent is a significant advantage, leading to early diagnosis and improved patient outcomes. The continuous advancements in PET technology and the integration with CT and MRI systems further enhance their clinical utility.
Planar Scintigraphy, the most traditional form of nuclear imaging, remains an essential tool in various medical applications. This method uses gamma cameras to capture two-dimensional images and is often employed in thyroid scans, bone scans, and renal imaging. While newer technologies have emerged, planar scintigraphy remains valuable for its cost-effectiveness and diagnostic efficiency in specific contexts. The ongoing research and development in this area aim to improve image quality and reduce radiation exposure, maintaining its relevance in the market.
Global Nuclear Imaging Devices And Equipment Market, Segmentation by Application
The Global Nuclear Imaging Devices And Equipment Market has been segmented by Application into Oncology, Cardiology, Neurology, and Other Applications (Orthopedics).
The Global Nuclear Imaging Devices and Equipment Market is a dynamic and rapidly evolving sector, characterized by its segmentation based on application areas. Primarily, the market is divided into four key segments: Oncology, Cardiology, Neurology, and Other Applications, which include Orthopedics. Each of these segments leverages nuclear imaging technology to enhance diagnostic accuracy and treatment efficacy.
In the field of Oncology, nuclear imaging devices are crucial for detecting and monitoring various types of cancers. These devices help in identifying the location and extent of tumors, enabling precise treatment planning and monitoring therapeutic responses. The rising prevalence of cancer globally has significantly driven the demand for advanced nuclear imaging techniques in this segment.
Cardiology is another major application area, where nuclear imaging plays a vital role in diagnosing and managing heart diseases. Techniques such as PET and SPECT scans provide detailed images of the heart, helping in the assessment of myocardial perfusion and viability, as well as identifying areas of ischemia or infarction. The growing incidence of cardiovascular diseases has propelled the adoption of nuclear imaging technologies in cardiology.
Global Nuclear Imaging Devices And Equipment Market, Segmentation by End User
The Global Nuclear Imaging Devices And Equipment Market has been segmented by End User into Hospitals, Imaging Centers, Academic & Research Institutes, and Other End Users (Pharmaceutical/Biotechnology Companies, and CROs).
The Global Nuclear Imaging Devices and Equipment Market is categorized by end-user into four distinct segments: hospitals, imaging centers, academic and research institutes, and other end users. Hospitals represent a significant portion of the market, driven by the increasing prevalence of chronic diseases and the need for advanced diagnostic tools. These facilities utilize nuclear imaging to enhance patient care through precise disease detection and management.
Imaging centers, another critical segment, are specialized facilities focusing solely on diagnostic imaging. They benefit from the growing demand for outpatient diagnostic services, providing high-quality imaging solutions outside the traditional hospital setting. This segment is expanding rapidly due to advancements in imaging technology and increased accessibility for patients.
Academic and research institutes contribute to the market by developing innovative nuclear imaging techniques and conducting clinical trials. These institutions play a vital role in advancing medical research, leading to the discovery of new diagnostic applications and the improvement of existing technologies. Their involvement ensures the continuous evolution and refinement of nuclear imaging practices.
Global Nuclear Imaging Devices And Equipment Market, Segmentation by Geography
In this report, the Global Nuclear Imaging Devices And Equipment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Nuclear Imaging Devices And Equipment Market Share (%), by Geographical Region, 2024
In 2023, the global nuclear imaging devices and equipment market exhibited diverse regional market shares, reflecting varied levels of adoption and healthcare infrastructure across the globe. North America emerged as the dominant region, capturing approximately 35% of the market share. This prominence is largely attributable to the region’s advanced healthcare system, significant investment in medical technology, and high prevalence of chronic diseases necessitating nuclear imaging procedures. The United States, in particular, plays a crucial role, driven by robust research and development activities and a strong presence of major market players.
Europe held the second-largest market share, accounting for around 25% of the global market. The region's substantial share can be linked to the well-established healthcare infrastructure in countries like Germany, France, and the United Kingdom. These countries have extensive adoption of advanced diagnostic technologies and supportive government policies that encourage the use of nuclear imaging for early disease detection and management. Additionally, increasing awareness about the benefits of early diagnosis and preventive healthcare further propels the market in this region.
The Asia-Pacific region is rapidly emerging as a significant market, representing approximately 20% of the global share. This growth is fueled by increasing healthcare expenditure, rising awareness about nuclear imaging technologies, and improving healthcare infrastructure in countries such as China, Japan, and India. The region’s expanding middle class and the growing burden of chronic diseases also contribute to the increasing demand for nuclear imaging devices and equipment. Government initiatives to enhance healthcare services and investments in medical technology further bolster the market’s growth in Asia-Pacific.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Nuclear Imaging Devices And Equipment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Technological advancements in nuclear imaging devices
- Increasing prevalence of chronic diseases
-
Rising geriatric population - The global nuclear imaging devices and equipment market is experiencing significant growth, driven largely by the rising geriatric population. As the elderly population increases, so does the prevalence of age-related diseases such as cardiovascular diseases, cancer, and neurological disorders. Nuclear imaging techniques, including positron emission tomography (PET) and single-photon emission computed tomography (SPECT), are crucial for early diagnosis and effective management of these conditions. This demographic shift is creating a substantial demand for advanced imaging solutions, which is propelling market expansion.
Advancements in technology are also playing a pivotal role in the growth of the nuclear imaging market. Modern nuclear imaging devices offer higher resolution, improved accuracy, and faster scanning times, enhancing the overall diagnostic process. Innovations such as hybrid imaging systems, which combine PET or SPECT with computed tomography (CT) or magnetic resonance imaging (MRI), provide comprehensive diagnostic information by integrating anatomical and functional imaging. These technological enhancements are increasing the adoption of nuclear imaging devices in medical facilities worldwide.
Increased healthcare expenditure and favorable government initiatives are boosting the market. Many countries are investing heavily in healthcare infrastructure, improving access to advanced diagnostic tools, including nuclear imaging devices. Government programs aimed at early detection and treatment of chronic diseases are further supporting market growth. Additionally, the rise of specialized diagnostic centers and the integration of nuclear imaging in routine clinical practice are expanding the market's reach.
Restraints
- High cost of nuclear imaging devices and procedures
- Stringent regulatory requirements
-
Limited availability of skilled professionals - The nuclear imaging sector has witnessed substantial growth due to advancements in medical technology and an increasing prevalence of chronic diseases. Technologies such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) have become integral in diagnosing and managing various health conditions, including cancer and cardiovascular diseases. However, this rapid technological progression has not been matched by a proportional increase in the availability of skilled professionals needed to operate these sophisticated devices. The disparity between technological growth and the workforce’s capability has created a significant bottleneck in the effective utilization of nuclear imaging technologies.
One of the primary reasons for the limited availability of skilled professionals is the complexity and specialized nature of nuclear imaging. Training for these roles requires a deep understanding of nuclear physics, radiopharmaceuticals, and advanced imaging techniques. Moreover, the education and certification process for nuclear medicine technologists and radiologists is extensive and rigorous, often necessitating years of specialized training and continuous education. Educational institutions and training programs are struggling to keep pace with the growing demand, leading to a scarcity of adequately trained professionals in the field.
Geographic disparities further exacerbate the shortage of skilled nuclear imaging professionals. While urban areas in developed countries may have relatively better access to trained personnel, rural and underdeveloped regions often face significant challenges. In many developing countries, the situation is even more dire, with limited infrastructure, inadequate training facilities, and insufficient investment in healthcare education. This uneven distribution of skilled professionals not only affects the quality of healthcare services but also limits the accessibility of advanced diagnostic imaging in resource-constrained settings.
Opportunities
- Emerging markets in developing countries
- Advances in radiopharmaceuticals
-
Increasing investment in healthcare infrastructure - The global nuclear imaging devices and equipment market is experiencing significant growth, driven by increasing investment in healthcare infrastructure. As countries around the world recognize the importance of advanced diagnostic tools in improving patient outcomes, substantial funds are being allocated towards upgrading and expanding healthcare facilities. This influx of investment is facilitating the adoption of cutting-edge nuclear imaging technologies, which are crucial for early detection and treatment of various diseases, including cancer and cardiovascular conditions.
In developing regions, the push to modernize healthcare systems is particularly strong. Governments and private entities are working together to build state-of-the-art hospitals and diagnostic centers equipped with the latest nuclear imaging devices. These efforts are aimed at bridging the gap in healthcare quality and accessibility, ensuring that a broader population can benefit from advanced medical imaging. This trend is also supported by international health organizations and non-governmental organizations (NGOs) that are providing financial and technical assistance to enhance medical infrastructure in underserved areas.
Technological advancements are also playing a pivotal role in the expansion of the nuclear imaging market. Innovations such as hybrid imaging systems, which combine positron emission tomography (PET) with computed tomography (CT) or magnetic resonance imaging (MRI), are becoming increasingly popular. These systems offer superior diagnostic capabilities by providing detailed anatomical and functional information in a single scan. The integration of artificial intelligence (AI) and machine learning (ML) in imaging devices is further enhancing diagnostic accuracy and efficiency, making these technologies indispensable in modern healthcare.
Competitive Landscape Analysis
Key players in Global Nuclear Imaging Devices And Equipment Market include :
- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Canon Medical Systems Corporation
- Hitachi Medical Corporation
- Neusoft Medical Systems Co., Ltd.
- Digirad Corporation
- DDD-Diagnostic A/S
- Mediso Medical Imaging Systems
- Positron Corporation
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Nuclear Imaging Devices And Equipment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Technological advancements in nuclear imaging devices
- Increasing prevalence of chronic diseases
- Rising geriatric population
- Restraints
- High cost of nuclear imaging devices and procedures
- Stringent regulatory requirements
- Limited availability of skilled professionals
- Opportunities
- Emerging markets in developing countries
- Advances in radiopharmaceuticals
- Increasing investment in healthcare infrastructure
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Nuclear Imaging Devices And Equipment Market, By Product Type, 2021 - 2031 (USD Million)
- SPECT systems
- PET systems
- Planar Scintigraphy
- Global Nuclear Imaging Devices And Equipment Market, By Application, 2021 - 2031 (USD Million)
- Oncology
- Cardiology
- Neurology
- Other Applications (Orthopedics, Urology, Thyroid-related Disorders, and Gastroenterology)
- Global Nuclear Imaging Devices And Equipment Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Imaging Centers
- Academic & Research Institutes
- Other End Users (Pharmaceutical/Biotechnology Companies and CROs)
- Global Nuclear Imaging Devices And Equipment Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Nuclear Imaging Devices And Equipment Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Canon Medical Systems Corporation
- Hitachi Medical Corporation
- Neusoft Medical Systems Co., Ltd.
- Digirad Corporation
- DDD-Diagnostic A/S
- Mediso Medical Imaging Systems
- Positron Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market